From the article: "Additionally, the results of the Z944 phase I/b study were only based on 16 samples; there is a high chance of failure in future trials, since the sample size was small."
What an idiot. I can't believe they let folks publish this junk. First, it's one sample with 16 observations... And SECOND, the fact that the sample size was small is in NO way predictive of the probability of a future failure. If anything, the ability to get p's
I like how he believes that the drop yesterday was based on the earnings report that revenues were down $100,000, and not the fact that an analyst for the stock tweeted out to the world that Z160 will fail.